Nicorandil [orch, phsu]
Management [ocac]
Stable angina [dsyn]
Including [ftcn]
High Risk [qlco]
Patients [podg]
Nicorandil [orch, phsu]
Adancor [orch, phsu]
R- [spco]
R- [spco]
Dancor [orch, phsu]
R- [spco]
R- [spco]
Europe [geoa]
Ikorel [orch, phsu]
R- [spco]
Europe [geoa]
Oceania [geoa]
R- [spco]
Japan [geoa]
Korea [geoa]
Taiwan [geoa]
Adenosine Triphosphate [bacs, nnon, phsu]
Sensitive [ftcn]
Potassium [elii]
K+ [elii, phsu]
Adenosine Triphosphate [bacs, nnon, phsu]
Channel [spco]
Agonist [phsu]
Nitrate [chvs]
properties [qlco]
Management [ocac]
Angina Pectoris, Stable [dsyn]
Well [qlco]
Established [qlco]
Anti-anginal [phsu]
activity [dora]
Added [ftcn]
Optimal [qlco]
Antianginal therapy [topp]
High Risk [qlco]
Patients [podg]
Stable angina [dsyn]
Twice daily [tmco]
Oral [spco]
Nicorandil [orch, phsu]
Alternative [cnce]
Addition [ftcn]
Antianginal therapy [topp]
Pharmacological [bmod]
properties [qlco]
Nitrate [chvs]
Nicorandil [orch, phsu]
Decrease [qlco]
Cardiac [bpoc]
dilating [ftcn]
Venous vessel [bpoc]
capacitance [qnco]
K+ [elii, phsu]
Adenosine Triphosphate [bacs, nnon, phsu]
Channel [spco]
Opening [spco]
Cardiac [bpoc]
Sustained [ftcn]
dilating [ftcn]
Action [ftcn]
Arterial [bpoc]
coronary [bpoc]
vasculature [bpoc]
Including [ftcn]
Coronary artery [bpoc]
Resistance [menp]
Vessels [bpoc]
Nicorandil [orch, phsu]
Heart [bpoc]
Ischaemic [ftcn]
Damage [inpo]
Single [popg]
Multiple [qnco]
Brief periods [fndg]
Ischaemia [dsyn]
Reperfusion [topp]
Often [tmco]
Prolonged [tmco]
Episode [tmco]
myocardial ischaemia [dsyn]
Exact [qlco]
Mechanism [ftcn]
Nicorandil [orch, phsu]
Understand [menp]
Activation [acty]
Mitochondrial [celc]
K+ [elii, phsu]
Adenosine Triphosphate [bacs, nnon, phsu]
Channel [spco]
Thought [menp]
Play [dora]
Patients [podg]
Percutaneous Transluminal Coronary Angioplasty [topp]
Orally [spco]
Administered [ftcn]
Nicorandil [orch, phsu]
Reduced [qlco]
ST segment elevation [fndg]
Ischaemia [dsyn]
QT [qnco]
Dispersion [spco]
Reperfusion [topp]
Suggest [idcn]
Nicorandil [orch, phsu]
APPEAR [qlco]
Myocardial metabolism [lbtr]
Energy [fndg]
Angina [sosy]
Patients [podg]
Exertion [orgf]
Oral [spco]
Nicorandil [orch, phsu]
coronary [bpoc]
Thrombus [patf]
formation [biof]
Improving [qlco]
fibrinolytic [topp]
Capacity [qnco]
activity [dora]
Plasminogen Activator Inhibitor 1 [aapp, bacs]
Patients [podg]
coronary artery disease [dsyn]
Maximum Concentration [qnco]
Plasma [bdsu]
Cmax [qnco]
Nicorandil [orch, phsu]
Hour [tmco]
Administration, Oral [topp]
Drug [phsu]
Absolute [qlco]
Bioavailability [qnco]
Approximate [qlco]
plasma concentration [qnco]
Dose [qnco]
Proportional [qlco]
Oral [spco]
Dose [qnco]
steady state [npop]
Reach [orgf]
4 Days [tmco]
Twice daily [tmco]
Administration [ocac]
steady state [npop]
Cmax [qnco]
Twice daily [tmco]
Oral [spco]
Nicorandil [orch, phsu]
Drug [phsu]
bound [spco]
Plasma Proteins [aapp, bacs]
apparent [idcn]
distribution [idcn]
Approximate [qlco]
KG [geoa]
Oral [spco]
Dose [qnco]
Single [popg]
Dose [qnco]
Nicorandil [orch, phsu]
Eliminated [qlco]
Plasma [bdsu]
8 Hours [tmco]
Residual [qlco]
plasma concentration [qnco]
hours [tmco]
Total body [ffas]
Clearance [qlco]
H+ [elii]
Therapeutic Efficacy [qlco]
Nicorandil [orch, phsu]
Administered [ftcn]
Orally [spco]
Twice daily [tmco]
Well [qlco]
Established [qlco]
Anti-anginal [phsu]
Efficacy [qlco]
Nitrates [chvs]
Isosorbide [carb, phsu]
DI [gngm]
beta adrenoceptor [moft]
antagonists [chvf]
Metoprolol [orch, phsu]
Propranolol [orch, phsu]
Atenolol [orch, phsu]
Calcium Channel Antagonists [moft]
Diltiazem [orch, phsu]
Amlodipine [orch, phsu]
Nifedipine [orch, phsu]
Large [qnco]
DOUBLE BLIND [resa]
IMPACT [gngm]
Nicorandil [orch, phsu]
Angina [sosy]
Study [mnob]
Patients [podg]
Stable angina [dsyn]
Additional [ftcn]
risk factors [qnco]
coronary [bpoc]
Event [evnt]
Nicorandil [orch, phsu]
placebo [topp]
Twice daily [tmco]
Added [ftcn]
Optimal [qlco]
Antianginal therapy [topp]
Coronary heart disease risk [inpr]
MODIFY [ftcn]
Drugs [phsu]
Nicorandil [orch, phsu]
Recipient [humn]
Reduced [qlco]
coronary heart disease [dsyn]
Myocardial Infarction [dsyn]
admission [hlca]
Cardiac chest pain [sosy]
Composite [qlco]
Primary Endpoint [irda]
Risk Reduction [inbe]
P NOS [aapp, imft]
0.014" [qnco]
placebo [topp]
Combined [qlco]
coronary heart disease [dsyn]
Myocardial Infarction [dsyn]
secondary [neop]
End Point [qlco]
Statistically [ocdi]
Nicorandil [orch, phsu]
Recipient [humn]
placebo [topp]
Recipient [humn]
Nicorandil [orch, phsu]
Recipient [humn]
Low Risk [fndg]
experience [menp]
Cardiovascular event [fndg]
Based [ftcn]
Composite [qlco]
cardiovascular events [fndg]
Acute Coronary Syndrome [dsyn]
coronary heart disease [dsyn]
Myocardial Infarction [dsyn]
Angina, Unstable [dsyn]
TOLERABILITY [resa]
Nicorandil [orch, phsu]
Well [qlco]
Clinical Trials [resa]
Maximum [qnco]
treatment [ftcn]
Open Label Study [resa]
Proportion [qnco]
Patients [podg]
experience [menp]
adverse events [fndg]
Nicorandil [orch, phsu]
treatment [ftcn]
Proportion [qnco]
Patients [podg]
experience [menp]
adverse effects [ftcn]
Nicorandil [orch, phsu]
Anti-anginal Agent [phsu]
Comparative Studies [inpr]
adverse events [fndg]
experience [menp]
Start [tmco]
Nicorandil [orch, phsu]
therapy [ftcn]
Decreased [qnco]
treatment [ftcn]
Headache [sosy]
Mild to moderate [qlco]
Severity [qlco]
Frequently [tmco]
Reported [inpr]
Drug [phsu]
Adverse event [fndg]
Nicorandil [orch, phsu]
treatment [ftcn]
Patients [podg]
Event [evnt]
Responsible [fndg]
Patients [podg]
Discontinue [fndg]
Nicorandil [orch, phsu]
therapy [ftcn]
Start [tmco]
Dosage [qnco]
APPEAR [qlco]
Discontinuation [hlca]
Progressive [ftcn]
Dose [qnco]
Titration [lbpr]
Recommended [idcn]
adverse events [fndg]
included [ftcn]
gastrointestinal [spco]
Events [evnt]
Dizziness [sosy]
Malaise [sosy]
Fatigue [sosy]
Age [orga]
Specific [qlco]
adverse events [fndg]
monitor [hlca]
reviewed [inpr]
Nicorandil [orch, phsu]
APPEAR [qlco]
Well [qlco]
Elderly [popg]
Patients [podg]
Reports [inpr]
Oral [spco]
Anal [bpoc]
Ulceration [patf]
Nicorandil [orch, phsu]
therapy [ftcn]
